Clinical Trials Directory

Trials / Completed

CompletedNCT01348399

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
2,000 (actual)
Sponsor
Seung-Jung Park · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate effectiveness and safety of XIENCE PRIME stent in the "real world" daily practice as compared with other drug eluting stents (DESs)

Detailed description

This study is a non-randomized, prospective, open-label registry to compare the effectiveness and safety of XIENCE PRIME stents versus other DESs in patients with coronary artery disease.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2014-07-01
Completion
2017-09-01
First posted
2011-05-05
Last updated
2018-06-20

Locations

29 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01348399. Inclusion in this directory is not an endorsement.